CY2342B1 - Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1H-benz(de)isoquinolin-1-one and intermediate product. - Google Patents

Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1H-benz(de)isoquinolin-1-one and intermediate product.

Info

Publication number
CY2342B1
CY2342B1 CY0300029A CY0300029A CY2342B1 CY 2342 B1 CY2342 B1 CY 2342B1 CY 0300029 A CY0300029 A CY 0300029A CY 0300029 A CY0300029 A CY 0300029A CY 2342 B1 CY2342 B1 CY 2342B1
Authority
CY
Cyprus
Prior art keywords
isoquinolin
benz
azabicyclo
tetrahydro
oct
Prior art date
Application number
CY0300029A
Other languages
English (en)
Inventor
Charles Alois Dvorak
Bruce Andrew Kowalczyk
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23040964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2342(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CY2342B1 publication Critical patent/CY2342B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CY0300029A 1994-07-08 2003-03-18 Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1H-benz(de)isoquinolin-1-one and intermediate product. CY2342B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/272,715 US5567818A (en) 1994-07-08 1994-07-08 Processes for preparing 2-(1-azabicyclo[2.2.2]oct-3-yl)-1H-benz[de] isoquinolin-1-one derivatives and intermediates useful therein

Publications (1)

Publication Number Publication Date
CY2342B1 true CY2342B1 (en) 2004-02-06

Family

ID=23040964

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0300029A CY2342B1 (en) 1994-07-08 2003-03-18 Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1H-benz(de)isoquinolin-1-one and intermediate product.

Country Status (16)

Country Link
US (1) US5567818A (de)
EP (1) EP0770077B1 (de)
JP (1) JP2898758B2 (de)
CN (1) CN1048727C (de)
AT (1) ATE205845T1 (de)
AU (1) AU2979995A (de)
BR (1) BR9508249A (de)
CL (2) CL2004001244A1 (de)
CY (1) CY2342B1 (de)
DE (1) DE69522808T2 (de)
DK (1) DK0770077T3 (de)
ES (1) ES2162929T3 (de)
FI (1) FI120198B (de)
MX (1) MX9700157A (de)
PT (1) PT770077E (de)
WO (1) WO1996001824A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL201703B1 (pl) 2000-04-20 2009-04-30 Masonite Corp Wyrób z kompozytu drewna dwukierunkowo ukształtowany i sposób jego wytwarzania oraz zestaw boazerii i dwukierunkowo ukształtowana okładzina drzwiowa, i jej sposób formowania jak również drzwi zawierające okładzinę drzwiową
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formulations of palonosetron
US8598219B2 (en) 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
US8614225B2 (en) * 2006-08-30 2013-12-24 Dr. Reddy's Laboratories Limited Process for the purification of palonosetron or its salt
US20100016593A1 (en) * 2006-10-23 2010-01-21 Pierluigi Rossetto Crystalline forms of palonosetron hydrochloride
JP2010512333A (ja) * 2006-12-07 2010-04-22 ヘルシン ヘルスケア ソシエテ アノニム 塩酸パロノセトロンの結晶及び非晶質形
EP2155199A4 (de) * 2007-05-29 2011-08-24 Chemagis Ltd Neue palonosetron-salze und verfahren zu ihrer herstellung und reinigung
WO2009010987A1 (en) * 2007-07-19 2009-01-22 Natco Pharma Limited An improved process for the preparation of pure palonosetron hydrochloride
AR069625A1 (es) * 2007-12-13 2010-02-03 Glenmark Generics Ltd Base libre de palonosetron y procedimiento para su preparacion
WO2009087643A1 (en) * 2008-01-11 2009-07-16 Natco Pharma Limited Novel crystalline forms of palonosetron hydrochloride
WO2009136405A1 (en) * 2008-05-05 2009-11-12 Natco Pharma Limited High purity palonosetron base and its solid state characteristics
EP2364312A4 (de) * 2008-11-11 2012-05-02 Reddys Lab Ltd Dr Herstellung von kristallinem palonosetron-hydrochlorid
CN101851233B (zh) * 2009-04-03 2013-03-06 四川滇虹医药开发有限公司 盐酸帕洛诺司琼和其前体化合物及制备
US20120267533A1 (en) 2009-06-30 2012-10-25 Ranbaxy Laboratories Limited Processes for the preparation of form i and form ii of palonosetron hydrochloride
WO2011013095A1 (en) 2009-07-31 2011-02-03 Ranbaxy Laboratories Limited Processes for the preparation of palonosetron
JP2014070036A (ja) * 2012-09-28 2014-04-21 Mitsubishi Gas Chemical Co Inc 1,8−テトラリンジカルボン酸無水物の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4007191A (en) * 1975-10-14 1977-02-08 E. R. Squibb & Sons, Inc. 2-(Piperidinyl or tetrahydropyridinyl)-alkyl)-2,3-dihydro-3-hydroxy-1H-benz(DE)isoquinolin-1-ones
AU642178B2 (en) * 1989-11-28 1993-10-14 Roche Palo Alto Llc New tricyclic compounds
US5202318A (en) * 1990-05-14 1993-04-13 Syntex (U.S.A.) Inc. Tricyclic compounds acting at serotonin receptor subtypes

Also Published As

Publication number Publication date
EP0770077B1 (de) 2001-09-19
EP0770077A1 (de) 1997-05-02
CN1152313A (zh) 1997-06-18
CN1048727C (zh) 2000-01-26
US5567818A (en) 1996-10-22
FI970068A7 (fi) 1997-01-07
PT770077E (pt) 2002-02-28
CL2007001958A1 (es) 2008-02-22
JPH09508645A (ja) 1997-09-02
BR9508249A (pt) 1998-01-06
DE69522808T2 (de) 2002-04-04
JP2898758B2 (ja) 1999-06-02
DE69522808D1 (de) 2001-10-25
ES2162929T3 (es) 2002-01-16
DK0770077T3 (da) 2002-01-14
FI120198B (fi) 2009-07-31
WO1996001824A1 (en) 1996-01-25
CL2004001244A1 (es) 2005-04-15
MX9700157A (es) 1997-04-30
ATE205845T1 (de) 2001-10-15
FI970068A0 (fi) 1997-01-07
AU2979995A (en) 1996-02-09

Similar Documents

Publication Publication Date Title
AU695352B2 (en) Process for producing derivatives of 4a,5,9,10,11,12,-hexahydro-6h-benzofuro{3a,3,2-ef}{2} benzazepine
AU2979995A (en) Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1h-benz(de)isoquinolin-1-one and intermediate product
AU2781997A (en) Process for the production of 1,4-butanediol, gamma-butyrolactone and tetrahydrofuran
AU4631596A (en) Process for the microbiological production of pha-polymers
SG43113A1 (en) Process for the preparation of lactam
HRP960253B1 (en) Process for the hydrogenation of imines
EP0673920A3 (de) Verfahren zur Herstellung von Ethanolaminen.
SG65610A1 (en) Process for the preparation of lactams
AU4729396A (en) Process for the preparation of 1,2-benzisothiazolin-3-ones
IL118788A0 (en) Process for the hydrogenation of imines
EP0690053A3 (de) Verfahren zur Herstellung von 2,5-Dihydrofuran
AU6657296A (en) Process for the hydrogenation of imines
GB9516444D0 (en) Process for the production of n,n-dimethyl-n'-phenylureas
AU6778796A (en) Process for the preparation of 1,4-butenediol
CA2370145A1 (en) Process of preparing a high-energy softening agent
EP0430096A3 (en) Process for the production of 3,4-epoxybutyrate and intermediate therefor
IL118731A0 (en) Process for the preparation of 2,2-dialkyl-arylidene-cycloalkanones
AU1681895A (en) Process for preparing 4,4-dialkyl-6-halo-chromans or thiochromans useful as pharmaceutical intermediates
AU6733596A (en) Process for the hydrogenation of imines
AU4300397A (en) Process for the manufacture of (2'-fluorophenyl)-3-halopyridines
IL120556A (en) Process for the preparation of 3,3,5-trichloroglutarimide
IL129511A (en) Method of making (1s, 4r)-1-azabicyclo [2.2.1] heptan-3-one and (1r, 4s) 1-azabicyclo [2.2.1] heptan-3-one
HUP9602374A3 (en) 2-azabicyclo[3,3,0]octan derivates, process for producing them and pharmaceutical compositions containing the same
HUP0100578A3 (en) Process for the preparation of 8-azabicyclo[3.2.1]octane derivatives and the novel intermediates
IL119112A0 (en) Process for the preparation of 4,6-dichloropyrimidines